Medical Debt Relief Act of 2025

Bill Number: H.R. 4827
Origin Chamber: House
Congress: 119th Congress, Session 1
Policy Area: Finance and Financial Sector
Status: Introduced
Latest Action: 2025-07-29: Referred to the House Committee on Financial Services.
Last Updated: 2026-07-01T21:20:52Z

AI-Generated Summary

Purpose of the Legislation

The Medical Debt Relief Act of 2025 aims to protect consumers by preventing medical debt from negatively affecting their credit reports and credit decisions. It amends the Fair Credit Reporting Act (FCRA), a federal law that regulates how credit information is collected and used, to exclude medical debt entirely from consumer credit files and restrict its use by lenders.

Key Provisions

Definition of Medical Debt: Adds a new term to the FCRA defining "medical debt" as any debt arising from medical services, products, or devices (e.g., hospital bills, doctor visits, or medical equipment costs).
Exclusion from Credit Reports: Prohibits consumer reporting agencies (like credit bureaus) from including any adverse information about medical debt on credit reports. This covers debts sent to collections, charged off as losses, or similar actions—no waiting period or conditions apply.
Technical Updates to FCRA: Removes outdated references in the FCRA that previously allowed limited medical information in certain reports (e.g., for employment or insurance purposes), ensuring consistency with the new exclusion.
Regulatory Changes by CFPB: Requires the Director of the Bureau of Consumer Financial Protection (CFPB, a federal agency overseeing consumer financial products) to update its regulations within one year. These updates will ban creditors (e.g., banks or lenders) from accessing or considering a consumer's medical debt when deciding whether to approve credit, such as loans or credit cards.

Significant Changes to Existing Law

Under current FCRA rules, medical debt could appear on credit reports after a one-year grace period (if under $500) or be included with restrictions, but it often harmed credit scores. This bill completely bans medical debt from reports, eliminating it as a factor in credit scoring.
It expands protections beyond reporting by directly prohibiting creditors from using medical debt data, building on the Equal Credit Opportunity Act (which prevents discrimination in lending) to close loopholes where lenders might indirectly access such information.

Potential Impacts

On Citizens: Could improve credit access for millions with medical debt (e.g., from unexpected illnesses), leading to better opportunities for loans, rentals, or jobs that check credit. This may reduce financial stress for low-income or uninsured individuals, as medical debt affects about 41 million Americans.
On Government Agencies: The CFPB must revise rules promptly, potentially increasing its workload in enforcement and consumer education. Credit bureaus may need to purge existing medical debt data from reports.
On International Relations: No direct impacts, as the bill focuses on domestic consumer protections.
Broader Effects: May lower overall credit risk perceptions for medical debtors, but could slightly increase lender caution or costs if they adapt to new data limitations.

Main Stakeholders Affected

Consumers: Primary beneficiaries, especially those with healthcare-related debts, who gain cleaner credit profiles.
Credit Reporting Agencies: Entities like Equifax, Experian, and TransUnion must stop including and remove medical debt, affecting their data practices.
Creditors and Lenders: Banks, credit card companies, and other financial institutions cannot use medical debt in decisions, potentially altering underwriting processes.
Healthcare Providers and Collectors: Hospitals, doctors, and debt collectors may see reduced leverage in billing, possibly leading to changes in how they pursue payments.
Federal Regulators: The CFPB leads implementation, with oversight from Congress's Financial Services Committee.

Notable Legal, Constitutional, or Political Implications

Legal Implications: Strengthens FCRA's consumer safeguards by treating medical debt like certain other protected information (e.g., non-financial personal details). It may lead to more lawsuits if violations occur, with enforcement through CFPB fines or private actions. The bill aligns with anti-discrimination laws by reducing bias in lending tied to health status.
Constitutional Implications: Supports equal protection under the law by mitigating barriers to economic opportunity for health-affected individuals, without raising free speech or due process concerns. It respects privacy rights by limiting sensitive health-related financial data sharing.
Political Implications: Introduced by a bipartisan group of House members and referred to the Financial Services Committee, it reflects growing consensus on healthcare affordability. If passed, it could set a precedent for further exclusions in credit reporting (e.g., other life-event debts), influencing future consumer finance debates.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Williams, Nikema [D-GA-5]

Cosponsors (17)

Rep. Correa, J. Luis [D-CA-46], Rep. Krishnamoorthi, Raja [D-IL-8], Rep. Scanlon, Mary Gay [D-PA-5], Rep. Kennedy, Timothy M. [D-NY-26], Rep. García, Jesús G. "Chuy" [D-IL-4], Rep. Thompson, Bennie G. [D-MS-2], Rep. Pocan, Mark [D-WI-2], Rep. Mullin, Kevin [D-CA-15], Rep. Thanedar, Shri [D-MI-13], Rep. Tlaib, Rashida [D-MI-12], Rep. Jackson, Jonathan L. [D-IL-1], Rep. Ocasio-Cortez, Alexandria [D-NY-14], Rep. Larson, John B. [D-CT-1], Rep. Latimer, George [D-NY-16], Rep. Magaziner, Seth [D-RI-2], Rep. Nadler, Jerrold [D-NY-12], Rep. Lee, Summer L. [D-PA-12]